JDD Corner

Intralesional Bleomycin Combined With Cryotherapy in the Treatment of Recalcitrant Verruca Vulgaris
BleomycinVerruca vulgaris is a common cutaneous manifestation of Human Papillomavirus (HPV) infection that presents as hyperkeratotic, cauliflower-like papules with central black petechiae. These lesions may be resistant to conventional therapies, posing a therapeutic challenge and prolong significant morbidity for the patient. This case report demonstrates an immediate and robust response of recalcitrant …
Bleomycin
For Sale Now! Digital Edition of The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas
[vc_row][vc_column][vc_column_text]   We have exciting news!  The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas DIGITAL EDITION is now available for purchase!  The atlas displays side-by-side images of the most commonly seen dermatology conditions in an array of skin tones and features: Real patients - real skin. No computer generated images 650+ fu …
JDD Issue Highlights | April 2022
psoriasisThe April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
psoriasis
Most Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery
Mohs Micrographic Surgery (MMS)INTRODUCTION Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to patients is difficult, and anxiety following a skin cancer diagnosis likely leads many to seek out additional resources to supplement their understanding.3,4 It is unclear how accurate and comp …
Mohs Micrographic Surgery (MMS)
Laboratory Testing in Telogen Effluvium
Telogen Effluvium (TE) Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. INTRODUCTION Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen Effluvium (TE)